Literature DB >> 1970362

Anticonvulsant action of the beta-carboline abecarnil: studies in rodents and baboon, Papio papio.

L Turski1, D N Stephens, L H Jensen, E N Petersen, B S Meldrum, S Patel, J B Hansen, W Löscher, H H Schneider, R Schmiechen.   

Abstract

Abecarnil (ZK 112119; isopropyl-6-benzyloxy-4-methoxymethyl-beta-carboxylate) is a metabolically stable beta-carboline derivative with potent anxiolytic and few sedative and ataxic effects in rodents. The anticonvulsant and muscle relaxant actions of abecarnil have been evaluated in mice, rats, gerbils and baboons. Abecarnil raised the threshold for tonic electroconvulsions in mice after corneal but not after auricular application, had no effect on maximal electroshock-induced tonic convulsions triggered by either method, protected mice against the tonic hindlimb extension in PTZ-, picrotoxin- and 3-mercaptopropionate-induced seizures and blocked clonus after PTZ, DMCM (methyl-4-ethyl-6,7-dimethoxy-9H-pyrido-(3,4-b)-indol-3-carboxylate) and 3-mercaptopropionate. Abecarnil had no effect on convulsions induced by bicuculline and strychnine. Furthermore, abecarnil blocked kindled seizures after chronic administration of PTZ and FG 7142 (beta-carboline-3-carboxylic acid methylamide) and protected mice and rats against limbic convulsions induced by pilocarpine. Severity and afterdischarge duration of amygdala-kindled seizures were reduced in rats treated with abecarnil. Abecarnil also antagonized selectively convulsions induced by i.c.v. administration of kainate, but not those triggered by N-methyl-D-aspartate or quisqualate. In genetic models of reflex epilepsy, abecarnil was effective against sound-induced convulsions in DBA/2 mice, against air blast-induced generalized seizures in gerbils and against myoclonus in baboons Papio papio. The anticonvulsant effect of abecornil in a PTZ seizure model in mice was potentiated by ethosuximide, whereas no significant potentiation was found with diazepam, clonazepam, diphenylhydantoin, carbamazepine and phenobarbital. Electromyographic monitoring in a etorphine model of muscle rigidity in rats showed no or little muscle relaxant effect of abecarnil.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1970362

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  12 in total

1.  Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice.

Authors:  F Natolino; A Zanotti; A Contarino; M Lipartiti; P Giusti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-11       Impact factor: 3.000

Review 2.  The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsy.

Authors:  Chris Rundfeldt; Wolfgang Löscher
Journal:  CNS Drugs       Date:  2014-01       Impact factor: 5.749

Review 3.  Molecular targets for antiepileptic drug development.

Authors:  Brian S Meldrum; Michael A Rogawski
Journal:  Neurotherapeutics       Date:  2007-01       Impact factor: 7.620

4.  Withdrawal precipitation by benzodiazepine receptor antagonists in dogs chronically treated with diazepam or the novel anxiolytic and anticonvulsant beta-carboline abecarnil.

Authors:  W Löscher; D Hönack
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

5.  Human studies on abecarnil a new beta-carboline anxiolytic: safety, tolerability and preliminary pharmacological profile.

Authors:  T Duka; B Schütt; W Krause; R Dorow; S McDonald; K Fichte
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

Review 6.  Molecular mechanisms of antiseizure drug activity at GABAA receptors.

Authors:  L John Greenfield
Journal:  Seizure       Date:  2013-05-14       Impact factor: 3.184

7.  Discriminative stimulus effects of midazolam and abecarnil in rats treated chronically with diazepam or abecarnil.

Authors:  D A Lytle; M W Emmett-Oglesby; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1995-10       Impact factor: 4.530

8.  Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies.

Authors:  G H Jones; C Schneider; H H Schneider; J Seidler; B J Cole; D N Stephens
Journal:  Psychopharmacology (Berl)       Date:  1994-03       Impact factor: 4.530

9.  The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist.

Authors:  H Yasumatsu; Y Morimoto; Y Yamamoto; S Takehara; T Fukuda; T Nakao; M Setoguchi
Journal:  Br J Pharmacol       Date:  1994-04       Impact factor: 8.739

10.  Interactions of the beta carboline abecarnil with the high pressure neurological syndrome in a primate model.

Authors:  P C Pearce; M J Halsey; C J MacLean; S Passingham; J Pearson; R L Mehta; B S Meldrum; C J Jordan; E M Ward
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.